Uni-Bio Science Group Ltd (HKEx: 690) announced that it has signed a strategic alliance agreement with China Resources Zizhu Pharmaceutical Co., Ltd. more info >>
Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group"; HKEx code: 690) has announced its audited annual results for the year ended 31 December 2015. more info >>
Uni-Bio Science Group Limited ("Uni-Bio Science" or the "Group;" HKEx code: 690) today announced that its long-acting Human Erythropoietin-Fc fusion protein injection ("Uni-EPO-Fc") has successfully completed the single ascending dose tolerability study of the Phase I clinical trial. more info >>
